melanotan 2 vial: Frequently asked questions

No—choose a lower reconstitution concentration instead. If you need 0.1mg per dose, reconstitute a 10mg vial with 20mL bacteriostatic water to create a 0.5mg/mL solution, then draw 0.2mL (200 microliters) per dose. This keeps your draw volume in the measurable range for standard insulin syringes. Larger vial sizes (20mg or 50mg) don't solve small-dose measurement problems—they just create more unused peptide degrading in the vial between administrations.

Discard it. Melanocortin receptor agonists in aqueous solution degrade rapidly above 15°C—eight hours at room temperature (20–25°C) can reduce potency by 30–50%, and there's no way to verify remaining activity without HPLC testing. The cost of replacing one vial is far lower than the cost of continuing a study with degraded peptide producing unreliable results. Unreconstituted lyophilised powder is more forgiving—if a sealed vial was shipped without refrigeration but arrived within 48 hours, it's likely still viable, though you should request a replacement or potency verification from the supplier.

The immediate contamination risk is low if you used sterile technique, but you've compromised the stopper's integrity. Each puncture creates a potential pathway for airborne contaminants to enter the vial during storage. If the vial will be used within 7–10 days, the risk is manageable. If you're planning to store it for the full 28-day window, consider reconstituting a fresh vial to eliminate the variable—especially for critical study phases where result reliability matters most.

You can extend storage slightly by reconstituting at higher concentrations (2mg/mL instead of 1mg/mL), which reduces the water volume and slows hydrolysis—but you're still working against oxidative degradation that bacteriostatic water doesn't prevent. Realistically, potency drops measurably after 28 days even under ideal refrigeration. If your study timeline extends beyond four weeks, reconstitute only the amount you'll use in that window and store the remaining powder unreconstituted at −20°C. A 10mg vial can be split across two reconstitution events if you work in a sterile environment, though this introduces additional contamination risk.

Use a medical-grade cooler that maintains 2–8°C for the entire travel duration. Standard insulin coolers like FRIO wallets use evaporative cooling and maintain safe temperatures for 36–48 hours without electricity or ice packs. Sufficient for most domestic travel. For longer trips, hard-sided coolers with gel packs replaced every 24 hours are necessary. Monitor with a min-max thermometer placed inside the cooler alongside the vial. If temperature exceeds 8°C at any point during travel, treat the vial as compromised and replace it upon return rather than continuing the protocol with degraded peptide.

Label every vial with reconstitution date using permanent marker directly on the glass or a dated adhesive label. If you cannot determine reconstitution date, apply the 28-day rule from your best estimate or discard and reconstitute fresh. Attempting to extend usage beyond 35 days based on guesswork introduces unacceptable dose variability. You're administering an unknown quantity of active peptide mixed with degradation products. Research protocols require dose consistency; undocumented vials cannot provide it.

Discard the vial. Reconstituted peptide solutions that freeze undergo ice crystal formation that mechanically shears peptide chains and disrupts the cyclic structure critical for MC1R binding. Unlike unreconstituted powder (which tolerates freezing), reconstituted peptide in aqueous solution experiences irreversible aggregation upon thawing. The solution may appear clear after thawing, but aggregated peptide fragments have reduced receptor affinity and unpredictable pharmacokinetics. Freezing is a terminal event for reconstituted peptides.

Discard the vial. A reconstituted Melanotan-2 vial exposed to room temperature (20–25°C) for 8–12 hours loses 10–20% potency through accelerated peptide bond hydrolysis. The degradation is irreversible. Refrigerating the vial afterward stops further degradation but doesn't restore lost bioactivity. More critically, bacterial contamination in bacteriostatic water accelerates exponentially at room temperature; benzyl alcohol inhibits growth at 2–8°C but becomes progressively less effective above 15°C. A vial left out overnight may appear clear and normal but harbors bacterial colonies producing proteolytic enzymes that will degrade remaining peptide over the next 48–72 hours even after returning to refrigeration.